跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,717 条关于
“HSCT-TMA”
全部
4,717
临床试验
3,690
药物
350
机构
23
资讯
654
上个月
Ultomiris Phase III Trial Misses Primary Endpoint in Adults with HSCT-TMA, But Paediatric Data Show Clinically Meaningful Survival Benefit
2个月前
EMA Rejects Omeros' Narsoplimab for Stem Cell Transplant Complication, Citing Insufficient Efficacy Data
4年前
EU Approves Apellis and Sobi's Aspaveli for PNH with Restricted Label
8个月前
FDA Approves First-Ever TA-TMA Therapy: Narsoplimab Shows 61% Response Rate in High-Risk Patients
去年
Iptacopan Shows Promise in Treating Life-Threatening Transplant-Associated Thrombotic Microangiopathy
去年
Narsoplimab Shows Significant Survival Benefit in TA-TMA Patients, BLA Resubmission Planned
3年前
MRD Status and Remission Number Impact HSCT Outcomes in AML
8个月前
Omeros Receives FDA Approval for First-in-Class TA-TMA Therapy YARTEMLEA
8个月前
FDA Approves YARTEMLEA as First Therapy for Life-Threatening Transplant Complication TA-TMA
去年
Narsoplimab Shows Promising Real-World Outcomes in TA-TMA Patients at 2025 Tandem Meetings
第 1 页,共 66 页
上一页
下一页